Analysis of Gal-4 expression in PDACs showed high expression of Gal-4 in 80% of patients without lymph node metastasis, whereas 70% of patients with lymph node metastases had low Gal-4 expression. This evidence concerns the gene LGALS4 and metastatic malignant neoplasm in the lymph nodes.